» Articles » PMID: 39344585

Methyltransferase-Like 3-Mediated N6-Methyladenosine RNA Methylation Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN

Overview
Date 2024 Sep 30
PMID 39344585
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary hypertension is a rare, progressive disorder that can lead to right ventricular hypertrophy, right heart failure, and even sudden death. N6-methyladenosine modification and the main methyltransferase that mediates it, methyltransferase-like (METTL) 3, exert important effects on many biological and pathophysiological processes. However, the role of METTL3 in pyroptosis remains unclear.

Methods And Results: Here, we characterized the role of METTL3 and the underlying cellular and molecular mechanisms of pyroptosis, which is involved in pulmonary hypertension. METTL3 was downregulated in a pulmonary hypertension mouse model and in hypoxia-exposed pulmonary artery smooth muscle cell. The small interfering RNA-induced silencing of METTL3 decreased the m6A methylation levels and promoted pulmonary artery smooth muscle cell pyroptosis, mimicking the effects of hypoxia. In contrast, overexpression of METTL3 suppressed hypoxia-induced pulmonary artery smooth muscle cell pyroptosis. Mechanistically, we identified the phosphate and tension homology deleted on chromosome 10 (PTEN) gene as a target of METTL3-mediated m6A modification, and methylated phosphate and tension homology deleted on chromosome 10 mRNA was subsequently recognized by the m6A "reader" protein insulin-like growth factor 2 mRNA-binding protein 2, which directly bound to the m6A site on phosphate and tension homology deleted on chromosome 10 mRNA and enhanced its stability.

Conclusions: These results identify a new signaling pathway, the METTL3/phosphate and tension homology deleted on chromosome 10/insulin-like growth factor 2 mRNA-binding protein 2 axis, that participates in the regulation of hypoxia-induced pyroptosis.

Citing Articles

Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.

Adu-Amankwaah J, You Q, Liu X, Jiang J, Yang D, Liu K MedComm (2020). 2025; 6(3):e70134.

PMID: 40066229 PMC: 11892029. DOI: 10.1002/mco2.70134.


The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.

Wang H, Han J, Kong H, Ma C, Zhang X Biomolecules. 2025; 15(2).

PMID: 40001550 PMC: 11853213. DOI: 10.3390/biom15020247.

References
1.
Zhaolin Z, Guohua L, Shiyuan W, Zuo W . Role of pyroptosis in cardiovascular disease. Cell Prolif. 2018; 52(2):e12563. PMC: 6496801. DOI: 10.1111/cpr.12563. View

2.
Xu S, Xu X, Zhang Z, Yan L, Zhang L, Du L . The role of RNA mA methylation in the regulation of postnatal hypoxia-induced pulmonary hypertension. Respir Res. 2021; 22(1):121. PMC: 8074209. DOI: 10.1186/s12931-021-01728-6. View

3.
Tuder R, Archer S, Dorfmuller P, Erzurum S, Guignabert C, Michelakis E . Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D4-12. PMC: 3970402. DOI: 10.1016/j.jacc.2013.10.025. View

4.
Xing Y, Qi J, Cheng X, Song X, Zhang J, Li S . Circ-myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia-Inducible Factor-1α Expression. J Am Heart Assoc. 2023; 12(7):e028299. PMC: 10122881. DOI: 10.1161/JAHA.122.028299. View

5.
Xing Y, Zheng X, Qi J, Fu Y, Cao W, Li J . 15-Lipoxygenase/15-hydroxyeicosanoid and activator protein 1 contribute to hypoxia-induced pulmonary artery smooth muscle cells phenotype alteration. Prostaglandins Leukot Essent Fatty Acids. 2018; 135:22-29. DOI: 10.1016/j.plefa.2018.03.002. View